G, L., AC, S., J, Z., D, T., & H, C. (2026). Impact of subanesthetic ketamine delivered via AmyloLipid nanovesicle (ALN)-based intranasal system on biobehavioral responses in an animal model of PTSD. Translational psychiatry, 16(1), . https://doi.org/10.1038/s41398-026-03979-7
Chicago Style (17th ed.) CitationG, Levi, Sintov AC, Zohar J, Todder D, and Cohen H. "Impact of Subanesthetic Ketamine Delivered via AmyloLipid Nanovesicle (ALN)-based Intranasal System on Biobehavioral Responses in an Animal Model of PTSD." Translational Psychiatry 16, no. 1 (2026). https://doi.org/10.1038/s41398-026-03979-7.
MLA (9th ed.) CitationG, Levi, et al. "Impact of Subanesthetic Ketamine Delivered via AmyloLipid Nanovesicle (ALN)-based Intranasal System on Biobehavioral Responses in an Animal Model of PTSD." Translational Psychiatry, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41398-026-03979-7.